Auditing and Reporting
Using EPCS Gold alone or in combination with Imprivata Confirm ID supports detailed reporting to establish a secure, auditable chain of trust for the entire EPCS process. This will help your organization prove compliance with DEA requirements.
e-Prescribing combined with biometric authentication allows customers to provide their physicians with the most convenient workflow to e-prescribe controlled substances. MEDITECH collaborates with DrFirst and Forward Advantage to address market and compliance-driven requirements such as these. With years of successful delivery of e-prescribing through DrFirst and advanced authentication technologies created by Imprivata and delivered by Forward Advantage, we are well positioned to collectively support all components of controlled substance e-prescribing.
To meet requirements for two-factor authentication at the time of prescribing, EPCS Gold includes provision of hard or soft one time password tokens. For optimal workflow, Imprivata Confirm ID enables the use of fingerprint biometric identification that meets FIPS-201 Personal Identity Verification requirements. This gives providers the flexibility to use the two-factor authentication process they prefer for ease of use and convenience when prescribing inside or outside the hospital.